🇺🇸 FDA
Pipeline program

Lurbinectedin

STUDY00003528

Phase 1 small_molecule active

Quick answer

Lurbinectedin for Extensive Stage Lung Small Cell Carcinoma is a Phase 1 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Extensive Stage Lung Small Cell Carcinoma
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials